These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. [Can lorazepam be distinguished from other short-acting benzodiazepines in regard to brain damage and withdrawal symptoms?]. van Hiele LJ Ned Tijdschr Geneeskd; 1981 Jan; 125(4):156. PubMed ID: 6111030 [No Abstract] [Full Text] [Related]
46. ["Depression and benzodiazepine dependence in the elderly"]. Kolitzus H Psychiatr Prax; 1995 Nov; 22(6):263. PubMed ID: 8570761 [No Abstract] [Full Text] [Related]
47. Long-term benzodiazepine use and depression. Nathan RG; Robinson D; Cherek DR; Davison S; Sebastian S; Hack M Am J Psychiatry; 1985 Jan; 142(1):144-5. PubMed ID: 2857068 [No Abstract] [Full Text] [Related]
48. Drug withdrawal. Hamlin M; Hammersley D Nurs Times; 1989 Aug 30-Sep 5; 85(35):66-8. PubMed ID: 2571137 [No Abstract] [Full Text] [Related]
49. The benzodiazepines. Hall RC; Kirkpatrick B Am Fam Physician; 1978 May; 17(5):131-4. PubMed ID: 26212 [TBL] [Abstract][Full Text] [Related]
50. Benzodiazepines--current safety issues. Bodemer W S Afr Med J; 1985 Oct; Suppl():26-7. PubMed ID: 2865822 [TBL] [Abstract][Full Text] [Related]
52. Benzodiazepine behavioral side effects: review and implications for individuals with mental retardation. Kalachnik JE; Hanzel TE; Sevenich R; Harder SR Am J Ment Retard; 2002 Sep; 107(5):376-410. PubMed ID: 12186578 [TBL] [Abstract][Full Text] [Related]
53. Doctors and detailers: the benzodiazepine scandal. Faust B Aust Nurses J; 1991 May; 20(9):12-3. PubMed ID: 1677804 [No Abstract] [Full Text] [Related]
55. Use of bromazepam in obsessional, phobic and related states. Burrell RH; Culpan RH; Newton KJ; Ogg GJ; Short JH Curr Med Res Opin; 1974; 2(7):430-6. PubMed ID: 4156004 [No Abstract] [Full Text] [Related]
56. Physical dependence on benzodiazepines? Drug Ther Bull; 1977 Oct; 15(22):85-6. PubMed ID: 22429 [No Abstract] [Full Text] [Related]
57. Haight Ashbury free clinics' drug detoxification protocols--Part 3: Benzodiazepines and other sedative-hypnotics. Hayner G; Galloway G; Wiehl WO J Psychoactive Drugs; 1993; 25(4):331-5. PubMed ID: 7907367 [No Abstract] [Full Text] [Related]
59. Benzodiazepines: tolerance and withdrawal: the clinician's point of view. Rickels K; Schweizer E; Case WG Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():102A-103A. PubMed ID: 1354016 [No Abstract] [Full Text] [Related]
60. Pearls and pitfalls in the approach to patients with neurotoxic syndromes. Rusyniak DE Semin Neurol; 2001 Dec; 21(4):407-16. PubMed ID: 11774056 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]